NCT04355611View on ClinicalTrials.gov

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

CompletedOBSERVATIONAL
Enrollment

2,465

Participants

Timeline

Start Date

April 17, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Multiple SclerosisNMO Spectrum DisorderCOVID-19
Interventions
OTHER

Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2)

Epidemiological characteristics of coronavirus infection (SARS-CoV-2) in patients with MS or NMO

Trial Locations (1)

75013

Hôpital Pitié Salpétrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04355611 - Epidemiological Characteristics of COVID-19 in Patients With MS or NMO | Biotech Hunter | Biotech Hunter